| Value | ₹0.34 Cr |
|---|
BSE filing, NSE: SARDAPPR. Summary written from the filing by ALFA Finder's alert engine.
Tahmar Enterprises Ltd: key numbers
- Share price
- ₹3.76
- Market cap
- ₹58.58 Cr
- Revenue (annual)
- ₹2.59 Cr
- Net profit (annual)
- ₹-5.60 Cr
- P/E (TTM)
- -13.8×Sector 22.8×
- Promoter holding
- 65.86%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tahmar Enterprises Ltd
All →Tahmar Enterprises Other Announcement
This quarterly shareholding pattern filing provides the shareholding distribution between promoters and public shareholders for the period ending September 30, 2026, as per SEBI regulations.
Tahmar Enterprises Management Change
Ms. Kanika Kabra has resigned as an Independent Director of Tahmar Enterprises Ltd, effective October 16, 2026, due to other professional commitments.
Tahmar Enterprises Other Announcement
Tahmar Enterprises Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, as received from its RTA, MUFG Intime India Private Limited.
Tahmar Enterprises Annual General Meeting
Tahmar Enterprises Ltd held its 35th Annual General Meeting on September 29, 2026. Shareholders adopted the annual financial statements and approved the proposed related party transactions.
Tahmar Enterprises Product Launch
Tahmar Enterprises approved entering the manufacture of Indian Made Foreign Liquor and Maharashtra Made Liquor at its existing distillery, with brand registration steps to follow.
Tahmar Enterprises Price Movement Clarification
Tahmar Enterprises replied to BSE's price-movement query, confirming no undisclosed information exists. The company stated the share price movement is purely market-driven.
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.